IPSC Collar Strategy
IPSC (Century Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell lymphoma that has relapsed or proven refractory to previous treatments. In addition to its lead candidate, the company's robust pipeline features several other therapeutic assets: CNTY-103: A CAR-iNK candidate aimed at CD133 + EGFR for recurrent glioblastoma. CNTY-102: A CAR-iT therapy targeting CD19 + CD79b, intended for relapsed or refractory B-cell lymphoma and other B-cell cancers. CNTY-104: A multi-specific CAR-iT or CAR-iNK candidate in development for acute myeloid leukemia.
IPSC (Century Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $200.8M, a beta of 1.57 versus the broader market, a 52-week range of 0.435-3.04, average daily share volume of 979K, a public-listing history dating back to 2021, approximately 140 full-time employees. These structural characteristics shape how IPSC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.57 indicates IPSC has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a collar on IPSC?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current IPSC snapshot
As of June 29, 2026, spot at $2.41, ATM IV 343.80%, IV rank 67.78%, expected move 98.56%. The collar on IPSC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this collar structure on IPSC specifically: IV regime affects collar pricing on both sides; mid-range IPSC IV at 343.80% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 98.56% (roughly $2.38 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IPSC expiries trade a higher absolute premium for lower per-day decay. Position sizing on IPSC should anchor to the underlying notional of $2.41 per share and to the trader's directional view on IPSC stock.
IPSC collar setup
The IPSC collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IPSC near $2.41, the first option leg uses a $2.53 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IPSC chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IPSC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $2.41 | long |
| Sell 1 | Call | $2.53 | N/A |
| Buy 1 | Put | $2.29 | N/A |
IPSC collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
IPSC collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on IPSC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on IPSC
Collars on IPSC hedge an existing long IPSC stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
IPSC thesis for this collar
The market-implied 1-standard-deviation range for IPSC extends from approximately $0.03 on the downside to $4.79 on the upside. A IPSC collar hedges an existing long IPSC position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current IPSC IV rank near 67.78% is mid-range against its 1-year distribution, so the IV signal is neutral; the collar thesis on IPSC should anchor more to the directional view and the expected-move geometry. As a Healthcare name, IPSC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IPSC-specific events.
IPSC collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IPSC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IPSC alongside the broader basket even when IPSC-specific fundamentals are unchanged. Always rebuild the position from current IPSC chain quotes before placing a trade.
Frequently asked questions
- What is a collar on IPSC?
- A collar on IPSC is the collar strategy applied to IPSC (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With IPSC stock trading near $2.41, the strikes shown on this page are snapped to the nearest listed IPSC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IPSC collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the IPSC collar priced from the end-of-day chain at a 30-day expiry (ATM IV 343.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IPSC collar?
- The breakeven for the IPSC collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IPSC market-implied 1-standard-deviation expected move is approximately 98.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on IPSC?
- Collars on IPSC hedge an existing long IPSC stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current IPSC implied volatility affect this collar?
- IPSC ATM IV is at 343.80% with IV rank near 67.78%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.